Medical Research Finder

Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

© 2026 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

Lacticaseibacillus rhamnosus & Diarrhea / Diarrhoea (antibiotic-induced) in children

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Register for a free trial

Navigation

Contents

Clinical data

The double-blind randomized clinical prevention trial XXX - Lacticaseibacillus rhamnosus GG (LGG) & Diarrhea / Diarrhoea (antibiotic-induced) in Children revealed that Lacticaseibacillus rhamnosus GG (LGG) effectively decreases the incidence of Diarrhea / Diarrhoea (antibiotic-induced) in children receiving oral antibiotics for common childhood infections (1)

References

(1) Vanderhoof et al. 1999 J. Pediatr. 135: 564–568

see also:
[Diarrhea / Diarrhoea (antibiotic-induced) in Children & Drugs/Treatments](brain://pB4uP36jLUOo9ej7hGm3zQ/Diarrh…

References (Sources)

Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children
Vanderhoof et al. 1999 J. Pediatr. 135: 564–568
Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults
Szajewska & Kołodziej 2015 Aliment Pharmacol Ther 42(10): 1149-57
Meta-Analysis
Review

AI Chat

7/1/2026

Chat with our artificial intelligence: